Dr. Dasari is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 2008 - 2011
- UPMC Medical EducationResidency, Internal Medicine, 2005 - 2008
- Gandhi Medical CollegeClass of 2002
Certifications & Licensure
- FL State Medical License 2021 - Present
- WA State Medical License 2022 - 2027
- AZ State Medical License 2022 - 2026
- GA State Medical License 2022 - 2026
- LA State Medical License 2022 - 2026
- TN State Medical License 2022 - 2026
- TX State Medical License 2011 - 2026
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors Start of enrollment: 2019 Jul 30
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Utilizing Patient Input in Rectal Cancer Trial Design.Janet Alvarez, Wini Zambare, Manju George, Reese Garcia, Phuong Gallagher
Journal of the National Cancer Institute. 2025-03-19 - 1 citationsHealth-related quality of life associated with fruquintinib in patients with metastatic colorectal cancer: Results from the FRESCO-2 study.Alberto Sobrero, Arvind Dasari, Jeneth Aquino, Sara Lonardi, Rocio Garcia-Carbonero
European Journal of Cancer. 2025-03-11 - Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.Lakshmi Rajdev, Gentry G King, Christopher H Lieu, Stacey A Cohen, Shubham Pant
JCO Precision Oncology. 2025-03-01
Press Mentions
- FDA Approves New Blood Test to Detect Colon CancerJuly 29th, 2024
- New Blood Test for Colorectal Cancer Approved by FDAJuly 29th, 2024
- FDA Approves Blood Test Method for Colon Cancer ScreeningJuly 29th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: